-
Mashup Score: 0Can AI-Powered Virtual Biopsies Improve Detection of Breast Lesion Subtypes on Digital Mammography? - 2 year(s) ago
In separate test sets of Israeli women and United States women who had either ductal carcinoma in situ or invasive breast cancer, emerging artificial intelligence (AI) algorithms achieved an area under the curve (AOC) of 88 percent and 80 percent, respectively, for malignancy detection.
Source: Diagnostic ImagingCategories: Latest Headlines, RadiologyTweet
-
Mashup Score: 0Can AI-Powered Virtual Biopsies Improve Detection of Breast Lesion Subtypes on Digital Mammography? - 2 year(s) ago
In separate test sets of Israeli women and United States women who had either ductal carcinoma in situ or invasive breast cancer, emerging artificial intelligence (AI) algorithms achieved an area under the curve (AOC) of 88 percent and 80 percent, respectively, for malignancy detection.
Source: Diagnostic ImagingCategories: Latest Headlines, RadiologyTweet-
Can #AI Powered Virtual Biopsies Improve Detection of Breast Lesion Subtypes on Digital #Mammography? https://t.co/1UbCoAqTS1 @ACRRFS @ACRYPS @RadiologyACR @ARRS_Radiology @RSNA @AAWR_org @RadiologyUcla @RadiologyUSC @StanfordRad @UTSW_Radiology @MayoRadiologyAZ #radiology #BCAM https://t.co/uwCCOP1nAh
-
-
Mashup Score: 1Mammography News: FDA Says National Breast Density Notification Rule May Be Published in Late 2022 or Early 2023 - 2 year(s) ago
In a recent letter to U.S. Rep. Rosa DeLauro (D-CT), the Food and Drug Administration (FDA) said a final rule on amendments to the Mammography Quality Standards Act (MQSA), including an oft-delayed national standard for breast density notification in mammography reporting, may be published in the next couple of months.
Source: Diagnostic ImagingCategories: Latest Headlines, RadiologyTweet
-
Mashup Score: 0Current Insights on Breast Density, Contrast-Enhanced Mammography and Supplemental Breast Cancer Screening - 2 year(s) ago
In a wide-ranging video interview, Wendie Berg, MD, PhD, discussed her family history with breast cancer, the founding of DenseBreast-info.org, emerging research with contrast-enhanced mammography and the need for a national standard on breast density notifications.
Source: Diagnostic ImagingCategories: Latest Headlines, RadiologyTweet-
Video: @DrWendieBerg discusses emerging insights on #BreastDensity, contrast-enhanced #mammography and much more. https://t.co/a3hRgurPgM @ACRRFS @ACRYPS @futureradres @BreastImaging @RadiologyACR @ARRS_Radiology @RSNA @RadiologyUcla @RadiologyUSC @UofURadiology #radiology #BCAM https://t.co/75PwcLCYzm
-
-
Mashup Score: 0Can AI-Powered Virtual Biopsies Improve Detection of Breast Lesion Subtypes on Digital Mammography? - 2 year(s) ago
In separate test sets of Israeli women and United States women who had either ductal carcinoma in situ or invasive breast cancer, emerging artificial intelligence (AI) algorithms achieved an area under the curve (AOC) of 88 percent and 80 percent, respectively, for malignancy detection.
Source: Diagnostic ImagingCategories: Latest Headlines, RadiologyTweet-
Can #AI Powered Virtual Biopsies Improve Detection of Breast Lesion Subtypes on Digital #Mammography? https://t.co/2QD3Qi50yd @ACRRFS @ACRYPS @RadiologyACR @ARRS_Radiology @RSNA @BreastImaging @PennRadiology @DukeRadiology @EmoryRadiology @UMichRadiology #radiology #BCAM #RadRes https://t.co/VmE6o9fQql
-
-
Mashup Score: 1Can AI-Powered Virtual Biopsies Improve Detection of Breast Lesion Subtypes on Digital Mammography? - 2 year(s) ago
In separate test sets of Israeli women and United States women who had either ductal carcinoma in situ or invasive breast cancer, emerging artificial intelligence (AI) algorithms achieved an area under the curve (AOC) of 88 percent and 80 percent, respectively, for malignancy detection.
Source: Diagnostic ImagingCategories: Latest Headlines, RadiologyTweet-
Can #AI Powered Virtual Biopsies Improve Detection of Breast Lesion Subtypes on Digital #Mammography? https://t.co/7XGxZpd7sw @ACRRFS @ACRYPS @RadiologyACR @ARRS_Radiology @RSNA @JBI_SBI @BreastImaging @PennRadiology @DukeRadiology @EmoryRadiology @michal_zvi #BCAM #radiology https://t.co/1YoujGfejs
-
-
Mashup Score: 1Trastuzumab Deruxtecan Could Challenge Frontline Trastuzumab/Pertuzumab Combo in HER2+ Breast Cancer - 2 year(s) ago
to Sara A. Hurvitz, MD, discussed the evolving treatment paradigm in HER2-positive breast cancer, ongoing research in the space, and developments in the treatment of triple-negative breast cancer.
Source: OncLiveCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1
A new study in mice by researchers at Baylor College of Medicine has investigated how breast cancer cells lose their estrogen receptor–positive (ER+) expression. Their findings reveal a mechanism that explains the process and potential possibilities to overcome it.
Categories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 1Rapid Reductions in Breast Density following Tamoxifen Therapy as Evaluated by Whole-Breast Ultrasound Tomography - PubMed - 2 year(s) ago
UST can image rapid declines in sound speed following initiation of tamoxifen. Given that sound speed and mammographic density are correlated, we propose that UST breast imaging may capture early responses to tamoxifen, which in turn may have utility in predicting therapeutic efficacy.
Source: PubMedCategories: Genetics, Latest HeadlinesTweet
-
Mashup Score: 50Find a Screening Program Near You | NBCCEDP | CDC - 2 year(s) ago
CDC’s National Breast and Cervical Cancer Early Detection Program (NBCCEDP) provides breast and cervical cancer screenings and diagnostic services to low-income, uninsured, and underinsured women across the United States.
Source: www.cdc.govCategories: General Medicine News, Latest HeadlinesTweet
Can #AI Powered Virtual Biopsies Improve Detection of Breast Lesion Subtypes on Digital #Mammography? https://t.co/fKlrJM7U7x @ACRRFS @ACRYPS @RadiologyACR @ARRS_Radiology @BreastImaging @JBI_SBI @SBIRFS @RadiologyUSC @StanfordRad @MayoRadiologyAZ @UofURadiology #radiology #BCAM https://t.co/qG0lmuCOLH